checkAd

     167  0 Kommentare Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing - Seite 3

    Media contacts:

    ACHIKO AG
    Investor Relations
    E: ir@achiko.com

    SWITZERLAND
    Marcus Balogh
    Farner Consulting Ltd.
    E: achiko@farner.ch
    T: +41 44 266 67 67

    GERMANY AND AUSTRIA
    Axel Mühlhaus / Dr Sönke Knop
    edicto GmbH
    E: achiko@edicto.de
    T: +49 69 90 55 05-51

    DISCLAIMER
    This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.


    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Achiko Concludes Phase 1 Study of Project Gumnuts for Covid-19 Testing - Seite 3 Completion of Phase 1 Testing Demonstrates 91% Sensitivity and 85% SpecificityFurther Optimization Studies are Currently Being Performed and are Expected to Continue to Improve Results and Match WHO StandardsNext Steps are Completion of Regulatory …